General Information of Drug Off-Target (DOT) (ID: OT1PXQIF)

DOT Name Piwi-like protein 2 (PIWIL2)
Synonyms EC 3.1.26.-; Cancer/testis antigen 80; CT80
Gene Name PIWIL2
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Adrenoleukodystrophy ( )
Advanced cancer ( )
Alcoholic liver diseases ( )
Breast disorder ( )
Carcinoma ( )
Cervical cancer ( )
Cholangiocarcinoma ( )
Colon cancer ( )
Colon carcinoma ( )
Colorectal carcinoma ( )
Dilated cardiomyopathy 1A ( )
Ductal carcinoma ( )
Endometrial cancer ( )
Endometrial carcinoma ( )
Germ cell tumor ( )
Glioma ( )
Leukoplakia ( )
Liver cirrhosis ( )
Male infertility ( )
Neoplasm ( )
Non-alcoholic fatty liver disease ( )
Obsolete male infertility with azoospermia or oligozoospermia due to single gene mutation ( )
Oral cancer ( )
Oral mucosa leukoplakia ( )
Osteoarthritis ( )
Precancerous condition ( )
Promyelocytic leukaemia ( )
Rheumatoid arthritis ( )
Seminoma ( )
Testicular cancer ( )
Testicular germ cell tumor ( )
Urinary bladder cancer ( )
Urinary bladder neoplasm ( )
Hepatocellular carcinoma ( )
Pancreatic cancer ( )
Recessive X-linked ichthyosis ( )
Sarcoma ( )
Soft tissue sarcoma ( )
Coeliac disease ( )
Thyroid cancer ( )
Thyroid gland carcinoma ( )
Thyroid gland papillary carcinoma ( )
UniProt ID
PIWL2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3O7X; 3QIR
EC Number
3.1.26.-
Pfam ID
PF08699 ; PF02170 ; PF02171
Sequence
MDPFRPSFRGQSPIHPSQCQAVRMPGCWPQASKPLDPALGRGAPAGRGHVFGKPEEPSTQ
RGPAQRESVGLVSMFRGLGIETVSKTPLKREMLPSGRGILGRGLSANLVRKDREELSPTF
WDPKVLAAGDSKMAETSVGWSRTLGRGSSDASLLPLGRAAGGISREVDKPPCTFSTPSRG
PPQLSSPPALPQSPLHSPDRPLVLTVEHKEKELIVKQGSKGTPQSLGLNLVKIQCHNEAV
YQYHVTFSPNVECKSMRFGMLKDHQAVTGNVTAFDGSILYLPVKLQQVLELKSQRKTDSA
EISIKIQMTKILEPCSDLCIPFYNVVFRRVMKLLDMKLVGRNFYDPTSAMVLQQHRLQIW
PGYAASIRRTDGGLFLLADVSHKVIRNDCVLDVMHAIYQQNKEHFQDECTKLLVGNIVIT
RYNNRTYRIDDVDWNKTPKDSFTMSDGKEITFLEYYSKNYGITVKEEDQPLLIHRPSERQ
DNHGMLLKGEILLLPELSFMTGIPEKMKKDFRAMKDLAQQINLSPKQHHSALECLLQRIA
KNEAATNELMRWGLRLQKDVHKIEGRVLPMERINLKNTSFITSQELNWVKEVTRDPSILT
IPMHFWALFYPKRAMDQARELVNMLEKIAGPIGMRMSPPAWVELKDDRIETYVRTIQSTL
GAEGKIQMVVCIIMGPRDDLYGAIKKLCCVQSPVPSQVVNVRTIGQPTRLRSVAQKILLQ
INCKLGGELWGVDIPLKQLMVIGMDVYHDPSRGMRSVVGFVASINLTLTKWYSRVVFQMP
HQEIVDSLKLCLVGSLKKFYEVNHCLPEKIVVYRDGVSDGQLKTVANYEIPQLQKCFEAF
ENYQPKMVVFVVQKKISTNLYLAAPQNFVTPTPGTVVDHTITSCEWVDFYLLAHHVRQGC
GIPTHYVCVLNTANLSPDHMQRLTFKLCHMYWNWPGTIRVPAPCKYAHKLAFLSGHILHH
EPAIQLCENLFFL
Function
Endoribonuclease that plays a central role during spermatogenesis by repressing transposable elements and preventing their mobilization, which is essential for the germline integrity. Plays an essential role in meiotic differentiation of spermatocytes, germ cell differentiation and in self-renewal of spermatogonial stem cells. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. During piRNA biosynthesis, plays a key role in the piRNA amplification loop, also named ping-pong amplification cycle, by acting as a 'slicer-competent' piRNA endoribonuclease that cleaves primary piRNAs, which are then loaded onto 'slicer-incompetent' PIWIL4. PIWIL2 slicing produces a pre-miRNA intermediate, which is then processed in mature piRNAs, and as well as a 16 nucleotide by-product that is degraded. Required for PIWIL4/MIWI2 nuclear localization and association with secondary piRNAs antisense. Besides their function in transposable elements repression, piRNAs are probably involved in other processes during meiosis such as translation regulation. Indirectly modulates expression of genes such as PDGFRB, SLC2A1, ITGA6, GJA7, THY1, CD9 and STRA8. When overexpressed, acts as an oncogene by inhibition of apoptosis and promotion of proliferation in tumors. Represses circadian rhythms by promoting the stability and activity of core clock components BMAL1 and CLOCK by inhibiting GSK3B-mediated phosphorylation and ubiquitination-dependent degradation of these proteins.
Tissue Specificity Expressed in adult testis and in most tumors.
Reactome Pathway
PIWI-interacting RNA (piRNA) biogenesis (R-HSA-5601884 )

Molecular Interaction Atlas (MIA) of This DOT

44 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Definitive Altered Expression [1]
Breast carcinoma DIS2UE88 Definitive Altered Expression [1]
Adrenoleukodystrophy DISTUD1F Strong Genetic Variation [2]
Advanced cancer DISAT1Z9 Strong Biomarker [3]
Alcoholic liver diseases DISXEPHQ Strong Biomarker [2]
Breast disorder DISJTGMA Strong Altered Expression [1]
Carcinoma DISH9F1N Strong Altered Expression [4]
Cervical cancer DISFSHPF Strong Biomarker [5]
Cholangiocarcinoma DIS71F6X Strong Altered Expression [6]
Colon cancer DISVC52G Strong Altered Expression [7]
Colon carcinoma DISJYKUO Strong Altered Expression [7]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [8]
Dilated cardiomyopathy 1A DIS0RK9Z Strong Altered Expression [1]
Ductal carcinoma DIS15EA5 Strong Altered Expression [1]
Endometrial cancer DISW0LMR Strong Biomarker [9]
Endometrial carcinoma DISXR5CY Strong Biomarker [9]
Germ cell tumor DIS62070 Strong Altered Expression [10]
Glioma DIS5RPEH Strong Biomarker [11]
Leukoplakia DIST3QD3 Strong Altered Expression [3]
Liver cirrhosis DIS4G1GX Strong Biomarker [2]
Male infertility DISY3YZZ Strong Altered Expression [12]
Neoplasm DISZKGEW Strong Altered Expression [13]
Non-alcoholic fatty liver disease DISDG1NL Strong Genetic Variation [2]
Obsolete male infertility with azoospermia or oligozoospermia due to single gene mutation DIS56JR8 Strong Autosomal recessive [14]
Oral cancer DISLD42D Strong Biomarker [3]
Oral mucosa leukoplakia DISJTL5X Strong Biomarker [3]
Osteoarthritis DIS05URM Strong Altered Expression [15]
Precancerous condition DISV06FL Strong Altered Expression [3]
Promyelocytic leukaemia DISYGG13 Strong Altered Expression [16]
Rheumatoid arthritis DISTSB4J Strong Altered Expression [15]
Seminoma DIS3J8LJ Strong Altered Expression [9]
Testicular cancer DIS6HNYO Strong Biomarker [17]
Testicular germ cell tumor DIS5RN24 Strong Biomarker [10]
Urinary bladder cancer DISDV4T7 Strong Biomarker [18]
Urinary bladder neoplasm DIS7HACE Strong Biomarker [18]
Hepatocellular carcinoma DIS0J828 moderate Altered Expression [19]
Pancreatic cancer DISJC981 moderate Altered Expression [13]
Recessive X-linked ichthyosis DISZY56W moderate Biomarker [20]
Sarcoma DISZDG3U moderate Biomarker [20]
Soft tissue sarcoma DISSN8XB moderate Biomarker [20]
Coeliac disease DISIY60C Limited Biomarker [21]
Thyroid cancer DIS3VLDH Limited Biomarker [5]
Thyroid gland carcinoma DISMNGZ0 Limited Biomarker [5]
Thyroid gland papillary carcinoma DIS48YMM Limited Altered Expression [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 44 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Methotrexate DM2TEOL Approved Methotrexate decreases the expression of Piwi-like protein 2 (PIWIL2). [22]
Marinol DM70IK5 Approved Marinol decreases the expression of Piwi-like protein 2 (PIWIL2). [23]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate increases the expression of Piwi-like protein 2 (PIWIL2). [24]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Piwi-like protein 2 (PIWIL2). [25]
------------------------------------------------------------------------------------

References

1 Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.Anticancer Res. 2018 Apr;38(4):2021-2030. doi: 10.21873/anticanres.12441.
2 Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China.BMJ Open. 2019 Jan 15;9(1):e023567. doi: 10.1136/bmjopen-2018-023567.
3 Expression of PIWIL2 in oral cancer and leukoplakia: Prognostic implications and insights from tumors.Cancer Biomark. 2019;26(1):11-20. doi: 10.3233/CBM-182009.
4 Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2.Cancer Res. 2010 Jun 1;70(11):4569-79. doi: 10.1158/0008-5472.CAN-09-2670. Epub 2010 May 11.
5 Differential expression of PIWIL2 in papillary thyroid cancers.Gene. 2018 Apr 5;649:8-13. doi: 10.1016/j.gene.2018.01.066. Epub 2018 Jan 31.
6 Expression and clinical significance of PIWIL2 in hilar cholangiocarcinoma tissues and cell lines.Genet Mol Res. 2015 Jun 26;14(2):7053-61. doi: 10.4238/2015.June.26.15.
7 Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.Exp Biol Med (Maywood). 2012 Oct;237(10):1231-40. doi: 10.1258/ebm.2012.011380. Epub 2012 Oct 26.
8 Correlation of HIWI and HILI Expression with Cancer Stem Cell Markers in Colorectal Cancer.Anticancer Res. 2015 Jun;35(6):3317-24.
9 Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway.Hum Mol Genet. 2006 Jan 15;15(2):201-11. doi: 10.1093/hmg/ddi430. Epub 2005 Dec 23.
10 Expression profiles of PIWIL2 short isoforms differ in testicular germ cell tumors of various differentiation subtypes.PLoS One. 2014 Nov 10;9(11):e112528. doi: 10.1371/journal.pone.0112528. eCollection 2014.
11 High expression of PIWIL2 promotes tumor cell proliferation, migration and predicts a poor prognosis in glioma.Oncol Rep. 2017 Jul;38(1):183-192. doi: 10.3892/or.2017.5647. Epub 2017 May 17.
12 Altered PIWI-LIKE 1 and PIWI-LIKE 2 mRNA expression in ejaculated spermatozoa of men with impaired sperm characteristics.Asian J Androl. 2018 May-Jun;20(3):260-264. doi: 10.4103/aja.aja_58_17.
13 The Prognosis Value of PIWIL1 and PIWIL2 Expression in Pancreatic Cancer.J Clin Med. 2019 Aug 22;8(9):1275. doi: 10.3390/jcm8091275.
14 A genomics approach to male infertility. Genet Med. 2020 Dec;22(12):1967-1975. doi: 10.1038/s41436-020-0916-0. Epub 2020 Jul 28.
15 Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis.PLoS One. 2016 Nov 28;11(11):e0166920. doi: 10.1371/journal.pone.0166920. eCollection 2016.
16 Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model.Syst Biol Reprod Med. 2018 Aug;64(4):225-239. doi: 10.1080/19396368.2018.1481465. Epub 2018 Jun 18.
17 The immunogenicity of a novel cytotoxic T lymphocyte epitope from tumor antigen PL2L60 could be enhanced by 4-chlorophenylalanine substitution at position 1.Cancer Immunol Immunother. 2013 Nov;62(11):1723-32. doi: 10.1007/s00262-013-1478-7.
18 Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients.Mol Med. 2015 May 13;21(1):371-80. doi: 10.2119/molmed.2014.00250.
19 Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma.Oncotarget. 2017 Jan 17;8(3):4607-4617. doi: 10.18632/oncotarget.13491.
20 Expression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patients.BMC Cancer. 2012 Jun 29;12:272. doi: 10.1186/1471-2407-12-272.
21 Celiac disease biomarkers identified by transcriptome analysis of small intestinal biopsies.Cell Mol Life Sci. 2018 Dec;75(23):4385-4401. doi: 10.1007/s00018-018-2898-5. Epub 2018 Aug 10.
22 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
23 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
24 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
25 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.